Insomnia Guide » 2008 » April

Mass High Tech: The Journal of New England Technology - Mass High Tech Neurogen Corp. via Bizjournals

From Insomnia News

“I agree to allow my personalized EEG recording to be emailed to Moscow so that my personalized recording can be created.”

Can the music of our brains make us sleep better? A South Bay psychologist says yes and is using mysterious Russian technology to treat patients with Brain Music Therapy. via Metroactive

From Insomnia News

“We are very happy to offer this technology to give consumers a great night’s sleep without compromising their health. This is truly an amazing product. It is easy to apply, drug free with no addiction and no side effects!”

Sleep disorders affect millions of people. According to the National Sleep Foundation’s national survey, 54% of adults said they have experienced at least one symptom of insomnia. via Press Release News From 24-7 Press Re…

From Insomnia News

“The best predictor of whether someone is going to fall asleep or not is an increase in their hand and foot temperature relative to their core”

The quest for rest is a battle more than 60 million Americans fight each night. Now, hope for insomnia sufferers could literally be in their hands. via WECT-TV Wilmington

From Insomnia News

“This is a landmark event for Orexo. We believe Meda is going to be an excellent marketing partner for Sublinox and OX-NLA with their pan-European and US presence”

Meda has acquired the exclusive world-wide commercialization rights from Orexo of two patented drugs in late development phase; Sublinox and OX-NLA. Sublinox contains the well-documented active substance … via BioSpace

From Insomnia News

“We can tell if they are awake, if they are asleep, what stage of sleep they are in, and watch their heart rate and oxygen.”

Recent research shows that lack of sleep can lead to obesity, diabetes, heart problems and increased risk for depression and substance abuse. via Lowell Sun

From Insomnia News

STOCKHOLM, Sweden - Regulatory News: Meda has acquired exclusive world-wide commercialisation rights from Orexo of two patented drugs in late development phase; Sublinox and OX-NLA. Sublinox contains the … via Earth Times

From Insomnia News

“Like everything else, your sleep clock ages, and as it does, it becomes less efficient”

Technician Arlene Abellana attaches monitoring devices to patient Chuck Deguara before he tries to nod off at the Sutter Sleep Disorders Center in Sacramento. via Sacramento Bee Newspaper

From Insomnia News

Parent-Reported Sleep Problems During Development and Self-reported Anxiety/Depression, Attention Problems, and Aggressive Behavior Later in Life April 9, 2008 at 8:42 am Filed under Mental health and substance … via Docuticker

From Insomnia News

“We’re going to focus more of our financial resources - all of our financial resources - into our development portfolio”

Pfizer is a major investor.

Merck is a partner.

But Neurogen Corp. of Branford is barely hanging on.

After losing money for most of 20 years - more than $50 million last year - the drug development company has bet the house that a drastic restructuring will give investors enough promising information to keep them interested. A pioneer of Connecticut’s biotech industry, Neurogen expects to close on a new $30.6 million financing deal in the coming days, it said this week.

The stock, which reached an all-time high of $47.37 in 2000, closed Thursday at $1.47 on the Nasdaq Stock Market. Shares are down 79 percent in the past 12 months, and on March 17 the company said its auditors have questioned its prospects as a going concern. Read more

From Insomnia News